These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30670900)

  • 41. Antimicrobial susceptibility monitoring of Mycoplasma hyopneumoniae isolated from seven European countries during 2015-2016.
    de Jong A; Youala M; Klein U; El Garch F; Moyaert H; Simjee S; Maes D; Gyuranecz M; Pridmore A; Thomson JR; Ayling RD;
    Vet Microbiol; 2021 Feb; 253():108973. PubMed ID: 33418394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of molecular methods for the rapid detection of antibiotic susceptibility of Mycoplasma bovis.
    Sulyok KM; Bekő K; Kreizinger Z; Wehmann E; Jerzsele Á; Rónai Z; Turcsányi I; Makrai L; Szeredi L; Jánosi S; Nagy SÁ; Gyuranecz M
    Vet Microbiol; 2018 Jan; 213():47-57. PubMed ID: 29292003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and Antimicrobial Susceptibility of Bovine
    Ammar AM; Abd El-Hamid MI; Mohamed YH; Mohamed HM; Al-Khalifah DHM; Hozzein WN; Selim S; El-Neshwy WM; El-Malt RMS
    Biology (Basel); 2022 Jul; 11(7):. PubMed ID: 36101462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of Minimum Inhibitory Concentrations for 154 Mycoplasma synoviae isolates from Italy collected during 2012-2017.
    Catania S; Bottinelli M; Fincato A; Gastaldelli M; Barberio A; Gobbo F; Vicenzoni G
    PLoS One; 2019; 14(11):e0224903. PubMed ID: 31697761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro antibiotic susceptibility of field isolates of Mycoplasma synoviae in Argentina.
    Cerdá RO; Giacoboni GI; Xavier JA; Sansalone PL; Landoni MF
    Avian Dis; 2002; 46(1):215-8. PubMed ID: 11922338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro and in vivo comparisons of valnemulin, tiamulin, tylosin, enrofloxacin, and lincomycin/spectinomycin against Mycoplasma gallisepticum.
    Jordan FT; Forrester CA; Ripley PH; Burch DG
    Avian Dis; 1998; 42(4):738-45. PubMed ID: 9876842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial susceptibility of
    Cid D; Fernández-Garayzábal JF; Pinto C; Domínguez L; Vela AI
    Acta Vet Hung; 2019 Dec; 67(4):489-498. PubMed ID: 31842595
    [No Abstract]   [Full Text] [Related]  

  • 48. Susceptibility of Arcanobacterium pyogenes from different sources to tetracycline, macrolide and lincosamide antimicrobial agents.
    Trinh HT; Billington SJ; Field AC; Songer JG; Jost BH
    Vet Microbiol; 2002 Apr; 85(4):353-9. PubMed ID: 11856585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro pharmacodynamics of gamithromycin against Mycoplasma mycoides subspecies mycoides Small Colony.
    Mitchell JD; Goh S; McKellar QA; McKeever DJ
    Vet J; 2013 Sep; 197(3):806-11. PubMed ID: 23810743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minimum inhibitory concentrations of selected antimicrobial agents for Moraxella bovoculi associated with infectious bovine keratoconjunctivitis.
    Angelos JA; Ball LM; Byrne BA
    J Vet Diagn Invest; 2011 May; 23(3):552-5. PubMed ID: 21908289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro activity of tylvalosin against Spanish field strains of Mycoplasma hyopneumoniae.
    Tavío MM; Poveda C; Assunção P; Ramírez AS; Poveda JB
    Vet Rec; 2014 Nov; 175(21):539. PubMed ID: 25185108
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro susceptibilities of caprine Mycoplasma agalactiae field isolates to six antimicrobial agents using the E test methodology.
    Filioussis G; Petridou E; Giadinis ND; Kritas SK
    Vet J; 2014 Dec; 202(3):654-6. PubMed ID: 25439442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing the in vitro effectiveness of antimicrobials against Mycoplasma mycoides subsp. mycoides small-colony type to reduce contagious bovine pleuropneumonia infection.
    Ayling RD; Bisgaard-Frantzen S; March JB; Godinho K; Nicholas RA
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5162-5. PubMed ID: 16304194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimicrobial susceptibility profiles of porcine mycoplasmas isolated from samples collected in southern Europe.
    Rosales RS; Ramírez AS; Tavío MM; Poveda C; Poveda JB
    BMC Vet Res; 2020 Sep; 16(1):324. PubMed ID: 32883288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Moraxella spp. isolated from field outbreaks of infectious bovine keratoconjunctivitis: a retrospective study of case submissions from 2010 to 2013.
    Loy JD; Brodersen BW
    J Vet Diagn Invest; 2014 Nov; 26(6):761-8. PubMed ID: 25261461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro susceptibility of Mycoplasma hyosynoviae and M. hyorhinis to antimicrobial agents.
    Kobayashi H; Sonmez N; Morozumi T; Mitani K; Ito N; Shiono H; Yamamoto K
    J Vet Med Sci; 1996 Nov; 58(11):1107-11. PubMed ID: 8959659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial Sensitivity Testing of
    Jelinski M; Kinnear A; Gesy K; Andrés-Lasheras S; Zaheer R; Weese S; McAllister TA
    Microorganisms; 2020 Jan; 8(1):. PubMed ID: 31963269
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparative minimum inhibitory and mutant prevention drug concentrations of enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin against bovine clinical isolates of Mannheimia haemolytica.
    Blondeau JM; Borsos S; Blondeau LD; Blondeau BJ; Hesje CE
    Vet Microbiol; 2012 Nov; 160(1-2):85-90. PubMed ID: 22677482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimicrobial susceptibility of Mycoplasma hyorhinis.
    Wu CC; Shryock TR; Lin TL; Faderan M; Veenhuizen MF
    Vet Microbiol; 2000 Sep; 76(1):25-30. PubMed ID: 10925038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimicrobial susceptibility profiles of Mycoplasma hyorhinis strains isolated from five European countries between 2019 and 2021.
    Klein U; Földi D; Belecz N; Hrivnák V; Somogyi Z; Gastaldelli M; Merenda M; Catania S; Dors A; Siesenop U; Vyt P; Kreizinger Z; Depondt W; Gyuranecz M
    PLoS One; 2022; 17(8):e0272903. PubMed ID: 35951622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.